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Placental pathology as a predisposing factor to intraventricular hemorrhage remains
a matter of debate, and its contribution to cerebellar hemorrhage development is still
largely unexplored. Our study aimed to assess placental and perinatal risk factors for
intraventricular and cerebellar hemorrhages in preterm infants. This retrospective cohort
study included very low-birth weight infants born at the Gaslini Children’s Hospital
between January 2012 and October 2016 who underwent brain magnetic resonance
with susceptibility-weighted imaging at term-equivalent age and whose placenta
was analyzed according to the Amsterdam Placental Workshop Group Consensus
Statement. Of the 286 neonates included, 68 (23.8%) had intraventricular hemorrhage
(all grades) and 48 (16.8%) had a cerebellar hemorrhage (all grades). After correction for
gestational age, chorioamnionitis involving the maternal side of the placenta was found to
be an independent risk factor for developing intraventricular hemorrhage, whereas there
was no association between maternal and fetal inflammatory response and cerebellar
hemorrhage. Among perinatal factors, we found that intraventricular hemorrhage was
significantly associated with cerebellar hemorrhage (odds ratio [OR], 8.14), mechanical
ventilation within the first 72 h (OR, 2.67), and patent ductus arteriosus requiring
treatment (OR, 2.6), whereas cesarean section emerged as a protective factor (OR,
0.26). Inotropic support within 72 h after birth (OR, 5.24) and intraventricular hemorrhage
(OR, 6.38) were independent risk factors for cerebellar hemorrhage, whereas higher
gestational age was a protective factor (OR, 0.76). Assessing placental pathology may
help in understanding mechanisms leading to intraventricular hemorrhage, although its
possible role in predicting cerebellar bleeding needs further evaluation.
Keywords: placenta, intraventricular hemorrhage, cerebellar hemorrhage, preterm infant, chorioamnionitis,
maternal malperfusion, magnetic resonance imaging
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INTRODUCTION
Despite significant improvements in the perinatal care of
preterm infants, intraventricular hemorrhage (GMH-IVH), and
cerebellar hemorrhage (CBH) still represent the most frequent
lesions occurring during the very first few days of life (1–
3). Besides ultrasonography, the implementation of magnetic
resonance imaging (MRI) with susceptibility-weighted image
(SWI) sequences as a diagnostic tool for preterm brain lesions
has improved the accuracy in detecting minor forms of both
supratentorial and infratentorial hemorrhages (4–7).
Both GMH-IVH and CBH have a multifactorial etiology
(8–10), in which gestational age and perinatal factors seem to
play a major role, although they have never been considered
together in relation to placental risk factors. In the last decades,
several studies have explored the contribution of the prenatal
environment to the development of preterm brain lesions (11). In
particular, the role of placental pathology in prematurity-related
complications has been widely investigated but is still a matter
of debate (12, 13). The heterogeneous results in different studies
could be explained by the multiplicity of both placental lesion
definition and classification.
In addition, whereas the majority of research has focused on
GMH-IVH, to date, the contribution of placental pathology to
CBH development is still largely unexplored. The aim of our
study was to evaluate the role of placental histopathological
features in the risk of developing GMH-IVH and CBH, which
was diagnosed with brain MRIs performed at term-equivalent
age (TEA) in a consecutive cohort of very low-birth weight
(VLBW) infants. We hypothesized that the use of both a uniform
and detailed placental histopathology classification and the use
of brain MRI with SWI sequences to detect even minor forms
of brain hemorrhage might better clarify the contribution of
placental pathology for the development of both GMH-IVH and
CBH in VLBW infants.
MATERIALS AND METHODS
The study was a retrospective analysis of a prospectively collected
cohort of all preterm infants born with a birth weight of
<1,500 g at Gaslini Children’s Hospital (Genoa, Italy) between
January 2012 and October 2016. Neonates were included if
they underwent a brain MRI at TEA and had a placental
pathology performed at birth.We excluded neonates with genetic
syndromes, congenital malformations, and brain malformations.
For GMH-IVH risk factor analysis, the case group included
infants with MRI showing any grade of GMH-IVH, and for
CBH risk factor analysis, the case group included infants with
punctate (≤4mm), limited (>4mm but less than one-third of the
cerebellar hemisphere), and massive (more than one-third of the
cerebellar hemisphere) hemorrhage.
Clinical Data Collection
Demographic and perinatal clinical data, including known risk
factors for prematurity-related brain lesions, were collected
by chart review. Prenatal variables included preeclampsia,
number of fetuses, twin-to-twin transfusion, intrauterine growth
restriction, antenatal steroids (two doses), gestational diabetes,
and type of delivery (vaginal delivery or elective/emergent
cesarean section). Neonatal variables included gestational age,
gender, birth weight, 1′ and 5′ Apgar scores, surfactant
administration, neonatal sepsis (early and late onset), necrotizing
enterocolitis, and patent ductus arteriosus (PDA) requiring
surgical or at least pharmacological treatment. Intubation,
mechanical ventilation, pneumothorax, and inotropic treatments
were recorded if they occurred within the first 72 h of life.
Brain MRI
BrainMRI scans were obtained at TEA (between 39 and 41 weeks
of corrected gestational age) according to our internal VLBW
follow-up protocol. Scans were performed on a 1.5-Tesla system
(Intera Achieva; Philips, Best, The Netherlands) using a pediatric
dedicated head/spine coil. The exam was performed during
natural sleep using the “feed and wrap” technique, whereas oral
midazolam (0.1 mcg/kg) was used for mild sedation to prevent
head motion in selected cases, according to the infant’s state
of arousal and image quality after the first sequence. Hearing
protection was provided for all patients. Heart rate and oxygen
saturation were monitored by pulse oximetry throughout the
examination. MRI scans of the brain included 3-mm-thick
axial T2- and T1-weighted images, 3-mm-thick coronal T2-
weighted images, 3-mm-thick sagittal T1-weighted images, axial
diffusion-weighted images (b value: 1,000 s/mm2), and axial
SWIs. Informed consent that included statements about the
significance and limitations of MRI at TEA was obtained in
all cases.
In order to assess the presence of GMH-IVH and CBH, all
images were reviewed by three neuroradiologists experienced in
neonatal neuroimaging (DT, GM, and MS), who were unaware
of perinatal history and placental pathology. Foci of signal loss
on SWI alongside lateral ventricle walls or in the caudothalamic
notch, without continuity suggestive of veins, were interpreted
as intraventricular or subependymal hemosiderin depositions,
consistent with previous GMH-IVH. Foci of signal loss on
SWI within the cerebellum, without continuity suggestive of
veins, were interpreted as hemosiderin depositions, consistent
with previous CBH. Similar SWI findings within the fourth
ventricle, potentially consistent with intraventricular blood of
supratentorial origin, were not interpreted as CBH.
Placental Pathology
Macroscopic examination results of each placenta were collected
from the electronic database of our pathology department,
and data about the presence of twin monochorionic placenta,
velamentous placental cord insertion, and retroplacental
hematoma were obtained from placental examination reports.
Three experienced placental pathologists (EF, FB, and MB)
reviewed placental sections for the microscopic analysis. The
following formalin-fixed sections of placental parenchyma, of
3–5µm thickness and stained with hematoxylin and eosin, were
analyzed for every patient: two or more sections of extraplacental
membrane roll, three cross sections of the umbilical cord, and 12
full-thickness sections of villous tissue, including one adjacent to
the umbilical cord insertion site.
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Maternal and fetal stromal–vascular lesions were classified
according to the Amsterdam Placental Workshop Group
Consensus Statement (14), and the degree of maternal and
fetal inflammatory response in ascending intrauterine infection
was scored according to Redline et al. (15) and confirmed
by the Amsterdam Placental Workshop Group Consensus
Statement (14). Maternal inflammatory responses were classified
as stage 1 (acute subchorionitis: patchy diffuse accumulations
of neutrophils in the subchorionic plate and/or membranous
chorionic trophoblast layer), stage 2 (acute chorioamnionitis:
more than a few scattered neutrophils in the chorionic plate or
membranous chorionic connective tissue and/or the amnion), or
stage 3 (necrotizing chorioamnionitis: degenerating neutrophils,
thickened eosinophilic amniotic basement membrane, and at
least focal amnionic epithelial degeneration). Fetal inflammatory
responses were classified as stage 1 (chorionic vasculitis/umbilical
phlebitis: neutrophils in the wall of any chorionic plate vessel or
the umbilical vein), stage 2 (umbilical vasculitis: neutrophils in
one or both umbilical arteries and vein), or stage 3 (necrotizing
funisitis or concentric umbilical perivasculitis: neutrophils,
cellular debris, eosinophilic precipitate, and/or mineralization
arranged in a concentric band, ring, or halo around one or
more umbilical vessels) (Figure 1). Grade/intensity for both
maternal and fetal inflammatory response was not included
in the analysis.
Maternal vascular malperfusion was defined by the presence
of the following microscopic features: accelerated villous
maturation, distal villous hypoplasia, villous infarction, and
decidual arteriopathy. Fetal vascular malperfusion was reported
in cases of thrombosis, segmental avascular villi, intramural
fibrin deposition, and villous stromal–vascular karyorrhexis. The
presence of villitis of unknown etiology (multiple foci on more
than one section, at least one of which showing inflammation
affecting more than 10 contiguous villi) and delayed villous
maturation (monotonous villous population with reduced
numbers of vasculosyncytial membranes) were recorded.
STATISTICAL ANALYSIS
Descriptive statistics were generated for the whole cohort,
and data were expressed as mean and standard deviation for
continuous variables. Median value and range were calculated
and reported, as were absolute or relative frequencies for
categorical variables. Demographic and clinical characteristics
were compared using the χ2 or Fisher’s exact test and
the Student t-test for categorical and continuous variables,
respectively. Univariate analysis was carried out to determine
which demographic, perinatal, and placental characteristics were
significantly more frequent among the patients with a specific
lesion (GMH-IVH or CBH). Logistic regression analyses were
used for each variable, and the results were reported as odds ratio
(OR) with their 95% confidence intervals (CIs). The absence of
exposure to the factor or the variable that was less likely to be
associated with the risk of the lesion was used as the reference
for each analysis. Multivariate analysis was then performed,
and only variables that proved to be statistically or borderline
significant in univariate analysis (P < 0.08) were included in the
model. The model showing the best fit was based on backward
stepwise selection procedures, and each variable was removed
if it did not contribute significantly. In the final model, a P <
FIGURE 1 | Placental sections showing the three stages of maternal and fetal inflammatory response. (A) Maternal inflammatory response—stage 1. (B) Maternal
inflammatory response—stage 2. (C) Maternal inflammatory response—stage 3. (D) Fetal inflammatory response—stage 1. (E) Fetal inflammatory response—stage 2.
(F) Fetal inflammatory response—stage 3.
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0.05 was considered statistically significant, and all P-values were
based on two-tailed tests. Statistical analysis was performed using
Statistical Package for the Social Sciences (SPSS) for Windows
(SPSS Inc, Chicago, IL).
RESULTS
A total of 348 VLBW infants were identified across the study
period. Of these, 26 (7.5%) patients died before reaching the TEA
and one (0.3%) patient was excluded from the study because
of the absence of brain MRI. Pathological examination of the
placenta was not performed in 35 (10%) cases. The remaining
286 (82.2%) subjects were included in the study. Of the 286
patients in the final study population, 135 were male (47.2%).
Mean gestational age was 28.2 weeks (standard deviation, SD
± 2.2 weeks), and mean birth weight was 1,040 g (SD ± 264 g).
Median 1′ and 5′ Apgar scores were 6 (range, 0–9) and 8 (range,
0–10). GMH-IVH of any grade was detected in 68 patients
(23.8%), whereas CHB was identified in 48 patients (16.8%). Of
note, 50/68 infants (73.5%) with MRI-diagnosed GMH-IVH had
already been diagnosed with cranial ultrasound, and the majority
of them (47/50, 94%) received the diagnosis within the first 72 h
of life. In addition, in the group of patients excluded because of
the absence of placental examination, we found no significant
difference in the incidence of GMH-IVH (10/35, 28.6%) nor CBH
(4/35, 11.4%) compared to the study population (p = 0.677 and
0.626, respectively).
Risk Factors for GMH-IVH
Demographic and perinatal clinical data are shown in Table 1.
Mean gestational age (27 ± 2.2 vs. 28.6 ± 2.1 weeks; P = 0.001)
and birth weight (908 ± 250 vs. 1,080 ± 255 g; P = 0.001)
were significantly lower in patients who developed GMH-IVH.
In the univariate analysis, infants with GMH-IVH were less
likely to be exposed to preeclampsia and delivered by cesarean
section (P = 0.04 and P ≤ 0.0001, respectively). Infants with
GMH-IVH had a significantly higher frequency of 5′ Apgar score
lower than five, intubation, mechanical ventilation, and inotropic
support within the first 72 h, surfactant, late-onset sepsis, and
medically and surgically treated PDA (Table 1). In addition, the
contemporary presence of CBH was significantly more frequent
in this population (P = 0.0001).
Placental findings of the two populations are shown in
Table 1. Across the spectrum of histological chorioamnionitis, in
the univariate analysis, severe maternal inflammatory response
(stage 3) and fetal inflammatory response (stage 2) were
associated with GMH-IVH (P = 0.007 and P = 0.04,
respectively). Conversely, maternal vascular malperfusion was
more frequent in infants without this lesion (P = 0.05).
As shown in Table 2, risk factors for GMH-IVH identified
by multivariate analysis adjusted for gestational age were the
presence of CBH (OR, 8.14; 95% CI, 3.63–18.24), mechanical
ventilation within the first 72 h (OR, 2.67; 95% CI, 1.23–5.79),
and pharmacologically treated PDA (OR, 2.6; 95%CI, 1.16–5.83).
In our cohort, both mild (stage 1) and severe (stage 3) maternal
inflammatory responses were found to be an independent risk
factor for developing GMH-IVH (OR, 2.92; 95% CI, 1.04–8.19
and OR, 4; 95% CI, 1.24–12.9, respectively). Cesarean section was
a protective factor (OR, 0.26; 95% CI, 0.11–0.58).
Risk Factors for Cerebellar Hemorrhage
Mean gestational age (26.6 ± 2 vs. 28.6 ± 2.1 weeks) and birth
weight (904 ± 254 vs. 1,067 ± 258 g) were significantly lower
in neonates with CBH (P = 0.0001). By univariate analysis,
intubation, mechanical ventilation, surfactant, hemodynamically
significant PDA, inotropic support, late-onset sepsis, and GMH-
IVHwere significantlymore frequent (Table 3). Among placental
factors, neither maternal or fetal vascular malperfusion nor
histologic chorioamnionitis (both maternal and fetal sides) was
associated with this lesion in our cohort. In the multivariate
analysis (Table 4), lower gestational age, inotropic support
within 72 h after birth (OR, 5.24; 95% CI, 1.88–14.6), and the
contemporary presence of GMH-IVH (OR, 6.38; 95% CI, 3.02–
13.5) emerged as independent risk factors for CBH.
DISCUSSION
Over the last decades, advances in perinatal care have contributed
to a consistent reduction in severe forms of prematurity-
related brain injuries such as periventricular leukomalacia (16).
Nevertheless, the same efforts have not been as effective in
reducing the incidence of GMH-IVH, which remains a common
brain lesion in preterm infants, affecting about one-third of
neonates of <32 weeks’ gestation (17, 18). Extremely preterm
infants are also prone to CBH, and after implementation of MRI
for studying neonatal brain, the reported prevalence of CBH
in low-birth weight infants went from 2% to a maximum of
nearly 20% (6, 19, 20). Both lesions have a significant negative
impact on neurodevelopmental outcome in preterm infants (21),
although the diagnosis of minor forms of hemorrhage is often
challenging with ultrasound and conventional MRI (4, 22) and
how these lesions affect neurodevelopment is still a matter of
debate (23, 24).
The multifactorial etiology and the relatively small
development time frame of GMH-IVH and CBH make their
prevention extremely challenging (25). For this reason, many
efforts have been made to deeply understand their etiopathology
as well as their associated risk factors. A complex interaction
between environmental and genetic factors contributes to
intraventricular hemorrhage in preterm infants (26). The role
of genetic factors has recently gained interest, although the
association with the development of GMH-IVH still remains
unclear (27). Studies investigating the role of thrombophilic
disorders increasing the risk of developing GMH-IVH are
consistent with the phenomenon of thrombosis in germinal
matrix vessels as a “primum movens” (10, 28–31), although
conflicting results have been also published (32). At the same
time, many studies found an increased risk of GMH-IVH
in neonates with gene polymorphisms of pro-inflammatory
cytokines, including IL-1β, IL-6, and TNF-α and of genes
associated with the regulation of systemic blood pressure and
cerebral blood flow, such as endothelial nitric oxide synthase
(33) and type IV collagen genes (34).
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N (%) N (%) N (%)
Prenatal data
Male 135 (47.2) 36 (52.9) 99 (45.4) 0.33
Intrauterine growth restriction 78 (27.3) 15 (22.1) 63 (28.9) 0.35
Antenatal corticosteroids 224 (78.6) 48 (70.6) 176 (80.7) 0.09
Gestational diabetes 11 (3.8) 2 (2.9) 9 (4.1) 1
Preeclampsia 64 (22.4) 9 (13.2) 55 (27.1) 0.04
Twin pregnancy 113 (39.5) 28 (41.2) 85 (39.0) 0.78
Twin to twin transfusion 22 (7.7) 5 (7.4) 17 (7.8) 1
Cesarean section 227 (79.4) 43 (63.2) 184 (84.4) ≤0.0001
Postnatal data
Gestational age at birth mean (SD), weeks 28.2 ± 2.2 27 ± 2.2 28.6 ± 2.1 0.001
Birth weight mean (SD), g 1040 ± 264 908 ± 250 1080 ± 255 0.001
1′ Apgar ≤ 5 114 (39.9) 34 (50) 80 (36.7) 0.06
5′ Apgar ≤ 5 11 (3.8) 7 (10.3) 4 (1.8) 0.005
Intubation within the first 72 h 205 (71.7) 61 (89.7) 144 (66.1) <0.0001
Mechanical ventilation within the first 72 h 149 (52.1) 49 (72.1) 100 (45.9) <0.0001
Surfactant administration 200 (69.9) 59 (86.8) 141 (64.7) <0.0001
Pneumothorax within the first 72 h 11 (3.8) 4 (5.9) 7 (3.2) 0.29
Inotropic support within the first 72 h 24 (8.4) 10 (14.7) 14 (6.4) 0.04
Early-onset sepsis 10 (3.5) 3 (4.4) 7 (3.2) 0.71
Late-onset sepsis 131 (45.8) 39 (57.4) 92 (42.2) 0.03
>1 late-onset sepsis 44 (15.4) 17 (25) 27 (12.4) 0.02
Necrotizing enterocolitis 17 (5.9) 5 (7.4) 12 (5.5) 0.56
Surgically treated necrotizing enterocolitis 10 (3.5) 4 (5.9) 6 (2.8) 0.25
Treated patent ductus arteriosus 174 (60.8) 51 (75) 123 (56.4) 0.007
Surgically treated patent ductus arteriosus 31 (10.8) 16 (23.5) 15 (6.9) <0.0001
Cerebellar hemorrhage 48 (16.8) 30 (44.1) 18 (8.3) 0.0001
Placental findings
Twin monochorionic placenta 38 (13.3) 7 (10.3) 31(14.2) 0.54
Velamentous placental cord insertion 27 (9.4) 5 (7.4) 22 (10.1) 0.64
Fetal inflammatory response—stage 1 23 (8) 9 (13.2) 14 (6.4) 0.09
Fetal inflammatory response—stage 2 9 (3.1) 5 (7.4) 4 (1.8) 0.04
Fetal inflammatory response—stage 3 23 (8) 6 (8.8) 17 (7.8) 0.80
Maternal inflammatory response—stage 1 29 (10.1) 11 (16.2) 18 (8.3) 0.06
Maternal inflammatory response—stage 2 37 (12.9) 8 (11.8) 29 (13.3) 0.84
Maternal inflammatory response—stage 3 22 (7.7) 11 (16.2) 11 (5) 0.007
Villitis of unknown etiology 31 (10.8) 10 (14.7) 21 (9.6) 0.26
Maternal vascular malperfusion 165 (57.7) 32 (47.1) 133 (61) 0.05
Fetal vascular malperfusion 11 (3.8) 3 (4.4) 8 (3.7) 0.73
Delayed villous maturation 44 (15.4) 8 (11.8) 36 (16.5) 0.26
Retroplacental hematoma 52 (18.2) 12 (17.6) 40 (18.3) 1
Statistically significant differences (p < 0.05) are highlighted in bold.
Gestational age and birth weight play a major role in the
development of GMH-IVH and CBH, and the lower the weight
and gestational age, the higher their incidence (19, 35). Our study
showed a strong relationship between low gestational age at birth
and CBH, in which the risk of this lesion was reduced at higher
gestational ages.
The fetal environment is likely to influence the development
of GMH-IVH and CBH because of the precocity of their
occurrence. As placental macroscopic and histologic features
reflect the quality of intrauterine life, several studies have focused
on placental pathology in order to assess whether an association
exists between placental lesions and the risk of developing
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OR (95% CI) P-value
N (%) N (%)
Cesarean section 43 (63.2) 184 (84.4) 0.26 (0.11–0.58) <0.001
Maternal inflammatory response—stage 1 11 (16.2) 18 (8.3) 2.92 (1.04–8.19) 0.04
Maternal inflammatory response—stage 3 11 (16.2) 11 (5) 4 (1.24–12.9) 0.02
Treated patent ductus arteriosus 51 (75) 123 (56.4) 2.6 (1.16–5.83) 0.02
Mechanical ventilation within the first 72 h 49 (72.1) 100 (45.9) 2.67 (1.23–5.79) 0.01
Cerebellar hemorrhage 30 (44.1) 18 (8.3) 8.14 (3.63–18.24) <0.001
OR, odds ratio; CI, confidence interval. Statistically significant differences (p < 0.05) are highlighted in bold.
neonatal brain injuries (12). Intrauterine inflammation/infection
(chorioamnionitis) is among the most studied placental lesions
associated with preterm birth and potentially with preterm-
related complications (36).
The relationship between chorioamnionitis and the
development of GMH-IVH is still a matter of debate. A
study in 2012 failed to find any association (37), whereas the
meta-analysis of Villamor-Martinez et al. (13) showed that
both clinical and histological chorioamnionitis constitute an
independent risk factor for GMH-IVH. In 2018, Granger et al.
demonstrated the same association, although after adjustment
for perinatal variables, this association disappeared (38). In
the same year, a multicenter study on 350 preterm infants
found no association between histological chorioamnionitis
and GMH-IVH diagnosed with early postnatal brain MRI (39).
Heterogeneous methodology of the studies, different criteria for
chorioamnionitis and brain damage diagnosis and staging, and
continuous improvement in the clinical care of preterm infants
(e.g., the introduction of antenatal steroid prophylaxis) could be
possible explanations for this discrepancy (40).
We observed that both mild and severe (stages 1 and
3) histopathologic chorioamnionitis involving the maternal
side of the placenta were independent risk factors for the
development of GMH-IVH. We observed that both stage 1
and stage 3 histopathologic chorioamnionitis were independent
risk factors for the development of GMH-IVH, while stage 2
chorioamnionitis did not show any significant association with
GMH-IVH in our cohort.
Besides, fetal inflammatory response, characterized by
chorionic vasculitis and different stages of funisitis, was
significantly more frequent in the GMH-IVH group only in
moderate forms (stage 2 fetal inflammatory response), but this
association disappeared in the multivariate analysis. The causal
relationship between chorioamnionitis and GMH-IVH is still
unclear (41, 42), although plausible mechanisms include the
direct effect of pro-inflammatory cytokines on the brain (43, 44),
the increased permeability of the brain–blood barrier (45), and
the augmented cerebral oxygen consumption associated with
antenatal infection/inflammation (46–48).
In our study, the maternal component of intrauterine
infection seemed to play a major role in enhancing the risk
of GMH-IVH regardless of the presence of fetal inflammatory
response. Our finding is consistent with the meta-analysis
of Villamor Martinez et al., who evaluated the effect of
funisitis on the development of intraventricular hemorrhage.
In an analysis of 13 studies regarding infants with histological
chorioamnionitis with or without funisitis, the authors did not
find a significant difference in GMH-IVH risk between these two
groups (13).
Maternal vascular malperfusion is a common placental
finding in preterm birth (49) and may be associated with
preeclampsia, stillbirth, intrauterine growth retardation, systemic
lupus erythematosus, and antiphospholipid antibody syndrome
(50). The placenta of nearly half of the VLBW infants in our
cohort showed signs of maternal vascular malperfusion. In the
univariate analysis, infants with GMH-IVH were less likely
to present with this placental feature, but after correction for
gestational age, this association disappeared.
In our cohort, histopathologic lesions of the placenta were not
associated with a higher risk of CBH. The lack of association
between cerebellar insult and chorioamnionitis is consistent with
a recent meta-analysis, which included five studies in which
clinically diagnosed chorioamnionitis was evaluated as a possible
risk factor for CBH (51).
Although predisposition to GMH-IVH and CBH may
potentially follow common perinatal patterns, it is possible that a
different vascular anatomymay partly modify the factors, making
these two brain regions predisposed to hemorrhage. Although
subependymal vein anatomy may facilitate venous congestion
leading to GMH-IVH (52), cerebellar vascular anatomy has not
been investigated in detail as a potential factor contributing
to CBH. In addition, human cerebellar development extends
from the early first trimester to final circuit maturity, which
is achieved by the end of the second postnatal year (53). The
protracted nature of human cerebellar development renders
this organ particularly vulnerable to developmental injury
after birth, in which postnatal preterm-related complications
may heavily impact its occurrence (4, 54), while antenatal
placental disturbances may not significantly predispose infants to
this lesion.
Among perinatal and postnatal risk factors, we found that
cesarean section exerts a protective role on the development of
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N (%) N (%) N (%)
Prenatal data
Male 135 (47.2) 26 (54.2) 109 (45.8) 0.34
Intrauterine growth restriction 78 (27.3) 8 (16.7) 70 (29.4) 0.08
Antenatal steroids 224 (78.6) 32 (66.7) 192 (80.7) 0.04
Gestational diabetes 11 (3.8) 1 (2.1) 10 (4.2) 0.70
Preeclampsia 55 (19.2) 8 (16.7) 56 (23.5) 0.35
Twin pregnancy 110 (38.5) 19 (39.6) 91 (38.2) 0.87
Twin-to-twin transfusion 227 (79.4) 35 (72.9) 192 (80.7) 0.24
Cesarean section
Postnatal data
Gestational age at birth mean (SD), weeks 28.2 ± 2.2 26.6 ± 2 28.6 ± 2.1 0.0001
Birth weight mean (SD), g 1040 ± 264 904 ± 254 1067 ± 258 0.0001
1′ Apgar ≤ 5 114 (39.9) 23 (47.9) 91 (38.2) 0.26
5′ Apgar ≤ 5 11 (3.8) 3 (6.2) 8 (3.4) 0.40
Intubation within the first 72 h 205 (71.7) 43 (89.6) 162 (68.1) 0.002
Mechanical ventilation within the first 72 h 149 (52.1) 32 (66.7) 117 (49.2) 0.03
Surfactant administration 200 (69.9) 43 (89.6) 157 (66) 0.001
Pneumothorax within the first 72 h 11 (3.8) 3 (6.2) 8 (3.4) 0.40
Inotropic support within the first 72 h 24 (8.4) 13 (27.1) 11 (4.6) 0.0001
Early-onset sepsis 10 (3.5) 3 (6.2) 7 (2.9) 0.38
Late-onset sepsis 131 (45.8) 34 (70.8) 97 (40.8) 0.0001
>1 late-onset sepsis 44 (15.4) 14 (29.2) 30 (12.6) 0.007
Necrotizing enterocolitis 17 (5.9) 3 (6.2) 14 (5.9) 1
Surgically treated necrotizing enterocolitis 10 (3.5) 3 (6.2) 7 (2.9) 0.38
Treated patent ductus arteriosus 174 (60.8) 32 (66.7) 142 (59.7) 0.42
Surgically treated patent ductus arteriosus 31 (10.8) 13 (27.1) 18 (7.6) 0.0001
GMH-IVH 68 (23.8) 30 (62.5) 38 (18) 0.0001
Placental findings
Twin monochorionic placenta 38 (13.3) 4 (8.3) 34(14.3) 0.35
Velamentous cord insertion 27 (9.4) 1 (2.1) 26 (10.9) 0.06
Fetal inflammatory response—stage 1 23 (8) 4 (8.3) 19 (8) 1
Fetal inflammatory response—stage 2 9 (3.1) 2 (4.2) 7 (2.9) 0.65
Fetal inflammatory response—stage 3 23 (8) 7 (14.6) 16 (6.7) 0.08
Maternal inflammatory response—stage 1 29 (10.1) 8 (16.7) 21 (8.8) 0.12
Maternal inflammatory response—stage 2 37 (12.9) 8 (16.7) 29 (12.2) 0.48
Maternal inflammatory response—stage 3 22 (7.7) 6 (12.5) 16 (6.7) 0.23
Villitis of unknown etiology 31 (10.8) 4 (8.3) 27 (11.3) 0.80
Fetal vascular malperfusion 11 (3.8) 1 (2.1) 10 (4.2) 0.70
Maternal vascular malperfusion 11 (3.8) 1 (2.1) 10 (4.2) 0.70
Delayed villous maturation 44 (15.4) 7 (14.6) 37 (15.5) 1
Retroplacental hematoma 52 (18.2) 11 (22.9) 41 (17.2) 0.41
Statistically significant differences (p < 0.05) are highlighted in bold.
both GMH-IVH and CBH compared to vaginal delivery. The
same conclusion regarding GMH-IVH has emerged from two
recent studies, in which elective cesarean section was found to
reduce the rates of GMH-IVH in large cohorts of preterm infants
born before 32 weeks’ gestation (11, 55). At the same time,
emergent cesarean section seems to increase the risk of CBH
(19, 56). Elective cesarean section improving preterm neonatal
outcomemay be explained by the advantages related to a planned
preterm birth, including an increased chance to administer a
complete corticosteroid and antibiotic prophylaxes before birth,
more attentive monitoring of fetal conditions, and perhaps, a
more efficient preparation of the neonatal resuscitation team
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OR (95% CI) P-value
N (%) N (%)
Gestational age 26.6 ± 2 28.6 ± 2.1 0.76 (0.63–0.91) 0.003
Inotropic support within the first 72 h 13 (27.1) 11 (4.6) 5.24 (1.88–14.6) 0.002
GMH-IVH 30 (62.5) 38 (18) 6.38 (3.02–13.5) 0.0001
OR, odds ratio; CI, confidence interval. Statistically significant differences (p < 0.05) are highlighted in bold.
(57, 58). Nevertheless, as we included both emergent and elective
sections, we are not able to confirm these associations.
Both circulatory and respiratory complications soon after
birth predispose infants to GMH-IVH. In very preterm infants,
cardiopulmonary resuscitation (35, 59–62), an increased number
of intubation attempts in the delivery room (63), and mechanical
ventilation (11, 64) were found to be risk factors for severe GMH-
IVH. In addition, several studies have reported that neonatal
hypotension increases the risk of both GMH-IVH and CBH
in extremely preterm infants in the 1st day of life (65–67),
possibly because of the immature cerebral autoregulation that
may affect the preterm brain (68). Our study confirmed that
a difficult adaptation to extrauterine life, demonstrated by a
5′ Apgar score <5, the presence of hemodynamic instability
caused by patency of ductus arteriosus, hypotension requiring
inotropic support, and the need for surfactant administration,
and intubation and mechanical ventilation in the 1st days of
life are likely to predispose the infant to both GMH-IVH and
CBH. As reported in previous studies on very preterm and
extremely preterm infants (11, 69), postnatal sepsis predisposed
infants to both GMH-IVH and CBH in our cohort, although
its effect was mitigated when corrected for gestational age. In
the multivariate analysis, pharmacologically treated PDA and
mechanical ventilation within the first 72 h remained significant
factors predisposing infants to GMH-IVH, whereas hypotension
requiring inotropic support within the first 72 h of life was an
independent risk factor for CBH.
Although predisposing factors for GMH-IVH and CBH
appear to be slightly different between our cohort and previous
studies (56), the chance to have both lesions is high (OR of having
a GMH-IVH in presence of CBH was 6.38 in our population
and OR of having a CBH in case of GMH-IVH was 8.14 in
our population). We suggest that preterm infants at risk for
one lesion should be monitored for both GMH-IVH and CBH;
interestingly, cerebral and cerebellar anatomical origins of the
bleeding share a similar function (3), germinal matrix for GMH-
IVH, and external granular layer for CBH, areas where neurons
are produced prior to take their final migratory destiny. Of note,
the major part of neuronal migration has already taken place in
the germinal matrix when GMH-IVH may occur, whereas the
external granular layer remains active in healthy infants until a
few months after birth (53, 70).
A strength of our study was the use of MRI with SWI
sequences to detect even minor forms of hemorrhage that
may escape detection not only by ultrasonography but also by
conventional magnetic resonance studies (71). In addition, we
considered both forms of hemorrhage, GMH-IVH and CBH. As
there is an urgent need for standardizing placental findings, we
reviewed placental sections of every neonate included according
to the recent histologic classification of the Amsterdam Placental
Workshop Group Consensus Statement (14), which provides
a detailed and comprehensive description of macroscopic and
microscopic placental lesions.
Limitations of our study were its retrospective nature and
the exclusion of all the patients who died before undergoing
brain MRI at TEA or without a placental histologic examination
performed at birth. This may have excluded the most preterm
and sick neonates in which high-grade GMH-IVH and CBH
are common complications. Due to the retrospective nature of
the study, we could not identify the reasons why the placental
examination was not performed. However, the prevalence of
both GMH-IVH and CBH in this subgroup of subjects excluded
from the analysis was similar to the prevalence we found in the
study population.
Our study stresses the importance of postnatal care in
the early neonatal period in reducing the risk of GMH-IVH
and CBH. In addition, our data confirm that the presence of
intrauterine infection/inflammation may play a significant role
in predisposing preterm infants to GMH-IVH and reinforce
the importance of preventing prenatal infections. Furthermore,
to our knowledge, this is the first study exploring the possible
association between placental pathology and hemorrhages like
GMH-IVH and CBH, diagnosed, and considered together with
SWI sequences. Despite the intuitive role of prenatal influence
in early neonatal lesions such as GMH-IVH and CBH, the
multifactorial etiology of these lesions and the strong influence
of early postnatal factors may modulate individual effects of the
prenatal environment on the subsequent risk of GMH-IVH and
CBH. We believe that the best way to discover more significant
risk factors differentiating the origin of the two lesions should
rely on prospective and multicenter studies comparing selected
cases of GMH-IVH (in the absence of CBH) to the even fewer
isolated CBH.
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